Literature DB >> 29101591

Successful IVIG treatment without discontinuation of TNF-α blocker in Guillain-Barre syndrome induced by adalimumab in patient with Crohn's disease.

Jong-Hak Lee1, Jin-Sung Park2, Donghwi Park3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29101591     DOI: 10.1007/s10072-017-3179-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

Authors:  Sean R Christensen; Jonathan Shupe; Kevin Nickerson; Michael Kashgarian; Richard A Flavell; Mark J Shlomchik
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 2.  Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review.

Authors:  Monica Cesarini; Erika Angelucci; Tiziana Foglietta; Piero Vernia
Journal:  J Crohns Colitis       Date:  2011-07-28       Impact factor: 9.071

3.  B cells regulate autoimmunity by provision of IL-10.

Authors:  Simon Fillatreau; Claire H Sweenie; Mandy J McGeachy; David Gray; Stephen M Anderton
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

4.  Spinal Cord Injury During Ultrasound-Guided C7 Cervical Medial Branch Block.

Authors:  Donghwi Park; Min Yong Seong; Ha Yong Kim; Ju Seok Ryu
Journal:  Am J Phys Med Rehabil       Date:  2017-06       Impact factor: 2.159

5.  Compression of Root Level in a Patient with Hereditary Neuropathy with Liability to Pressure Palsy Diagnosed by Magnetic Resonance Imaging.

Authors:  Donghwi Park; Ju Seok Ryu; Ki-Jeong Kim
Journal:  Am J Phys Med Rehabil       Date:  2016-09       Impact factor: 2.159

  5 in total
  1 in total

1.  Usefulness of polydeoxyribonucleotide as an alternative to corticosteroids in patients with lateral epicondyitis: A case series.

Authors:  Goo Joo Lee; Donghwi Park
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.